>>On the Market

Healthcare Professionals: Please visit the Aggrastat product website.

>>In Development

Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
Read more..

>>Latest News

August 13, 2014
Medicure Provies Updates on Tardoxal and TEND-TD Study Read more

July 11, 2014
Medicure Announces Shares for Debt Settlement Read more

July 7, 2014
Medicure Announces Grant of Options Read more

Sign up to receive email updates such as Press Release nofications and other company news.

>>Clinical Trials

SAVI-PCI
Read more on clinicaltrials.gov

TEND TD
Read more on clinicaltrials.gov

>>A Heart for Life

Medicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human
therapeutics. Find out more.